biomarker

Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset Jenny Hällqvist, Michael Bartl, Mohammed Dakna, Sebastian Schade, Paolo Garagnani, Maria-Giulia Bacalini, Chiara Pirazzini, Kailash Bhatia, Sebastian Schreglmann, Mary Xylaki, Sandrina Weber...

Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID Sylwia D Tyrkalska, Fernando Pérez-Sanz, Lorena Franco-Martínez, Camila P Rubio, Asta Tvarijonaviciute, Silvia Martínez-Subiela, María Méndez-Hernández, Alba González-Aumatell, Clara...

I often hear the claim that the reason ME/CFS is neglected psychologised etc. is that we don’t have a biomarker for the disease. In my opinion, it is a possibility that we have a biomarker within the next decade, even though it might only be usable in specialist laboratories. How do you think...

Link to published version: https://www.s4me.info/threads/long-covid-plasma-levels-of-neurofilament-light-chain-in-mild-covid-19-patients-with-neurocognitive-symptoms-2023-gutman-et-al.33354/#post-529159 *** Preprint It is well known the potential of severe acute respiratory coronavirus type 2...

Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis Chico-Sordo, Lucía; Ruiz-Martínez, Tamara; Toribio, Mónica; González-Martín, Roberto; Spagnolo, Emanuela; Domínguez, Francisco; Hernández, Alicia; García-Velasco, Juan A. The diagnosis of...

Published as a preprint. See post #7 And now published in final form - link here ****** This is an abstract from the Demystifying Long COVID International Conference 2023, converted from an image on Twitter, so it might be slightly wonky, but it looks intriguing. Blood Transcriptomics Reveal...

Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection Hanson; Visvabharathy; Orban; Jimenez; Batra; Liotta; DeLisle; Klausner; Cohen; Padhye; Tachas; Koralnik Persistent symptoms of COVID-19...

Merged thread, link and abstract added to post https://academic.oup.com/jes/article/7/Supplement_1/bvad114.1370/7290078 THU581 Possible Markers For Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Developed In Long Covid: Utility Of Serum Ferritin And Insulin-like Growth Factor-I...

YouTube: IIMEC15 07 Professor Alain Moreau 15th Invest in ME Research International ME Conference 2023 Discussion of potential biomarkers in ME/LC subgroups. References upcoming, unpublished work. Highlighted time-stamps — 9:07 MicroRNAs 18:18 SMPDL3B 27:03 FGF-21 SMPDL3B is Sphingomyelin...

Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges Tsilingiris, Dimitrios; Vallianou, Natalia G.; Karampela, Irene; Christodoulatos, Gerasimos Socrates; Papavasileiou, Georgios; Petropoulou...

Development of a digital biomarker and intervention for subclinical depression: study protocol for a longitudinal waitlist control study Gisbert W. Teepe, Yanick X. Lukic, Birgit Kleim, Nicholas C. Jacobson, Fabian Schneider, Prabhakaran Santhanam, Elgar Fleisch & Tobias Kowatsch Abstract...

Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifaceted condition that affects most body systems. There is currently no known diagnostic biomarker; instead, diagnosis is dependent on application of symptom-based case criteria following exclusion of any...

The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis Kimber-Trojnar, Żaneta; Pilszyk, Aleksandra; Niebrzydowska, Magdalena; Pilszyk, Zuzanna; Ruszała, Monika; Leszczyńska-Gorzelak, Bożena Endometriosis is a disease that affects women of...

As the title asks. “Well recognized” means that the diagnosis is uncontroversial in conventional medicine. The obvious one is Alzheimer’s but there may be other such syndromes and diseases. If considered to be neurological diseases, or at least primarily biological in nature, this applies to...

WebMD: Researchers Hunt Biomarkers – Potential Keys to Long COVID https://www.webmd.com/covid/news/20230106/researchers-hunt-long-covid-biomarkers Brief mention of ME/CFS:

Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C...

Abstract Background Long-COVID is characterized by prolonged, diffuse symptoms months after acute COVID-19. Accurate diagnosis and targeted therapies for Long-COVID are lacking. We investigated vascular transformation biomarkers in Long-COVID patients. Methods A case–control study utilizing...

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome Gravelsina Sabine, Vilmane Anda, Svirskis Simons, Rasa-Dzelzkaleja Santa, Nora-Krukle Zaiga, Vecvagare Katrine, Krumina Angelika, Leineman Iana, Shoenfeld Yehuda, Murovska Modra Myalgic...

The use of oxygen as a possible screening biomarker for the diagnosis of chronic fatigue Fernando Pifarréa, Lluís Rossellób, Raúl Hilenoc, Joan Palmic, Llúcia Bañeresc, Antoni Planasc, Joan Antoni Prat Abstract Background The aim of this study was to verify whether the mean percentage of...

Full title: Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic disease characterized by long-lasting persistent...